vs
Side-by-side financial comparison of ACNB CORP (ACNB) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $47.2M, roughly 1.0× ACNB CORP). ACNB CORP runs the higher net margin — 22.9% vs -4.8%, a 27.7% gap on every dollar of revenue. On growth, ACNB CORP posted the faster year-over-year revenue change (42.2% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $52.6M). Over the past eight quarters, ACNB CORP's revenue compounded faster (22.1% CAGR vs -20.2%).
ACNB Corp is a US-based financial holding company headquartered in Pennsylvania. It provides a full suite of financial solutions including retail and commercial banking, wealth management, trust services, and property & casualty insurance products. Its core market covers local communities, individual consumers, and small-to-medium enterprises across south-central Pennsylvania and northern Maryland.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
ACNB vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $47.7M |
| Net Profit | $10.8M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 27.9% | 14.3% |
| Net Margin | 22.9% | -4.8% |
| Revenue YoY | 42.2% | -47.3% |
| Net Profit YoY | 63.8% | -200.9% |
| EPS (diluted) | $1.10 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.2M | $47.7M | ||
| Q3 25 | $50.9M | $122.1M | ||
| Q2 25 | $50.3M | $85.2M | ||
| Q1 25 | $43.5M | $41.1M | ||
| Q4 24 | $33.2M | $90.5M | ||
| Q3 24 | $34.1M | $91.6M | ||
| Q2 24 | $33.3M | $94.4M | ||
| Q1 24 | $31.6M | $74.9M |
| Q4 25 | $10.8M | $-2.3M | ||
| Q3 25 | $14.9M | $40.1M | ||
| Q2 25 | $11.6M | $23.6M | ||
| Q1 25 | $-272.0K | $-37.4M | ||
| Q4 24 | $6.6M | $2.3M | ||
| Q3 24 | $7.2M | $3.6M | ||
| Q2 24 | $11.3M | $-860.0K | ||
| Q1 24 | $6.8M | $-4.2M |
| Q4 25 | 27.9% | 14.3% | ||
| Q3 25 | 37.2% | 61.8% | ||
| Q2 25 | 29.7% | 53.2% | ||
| Q1 25 | -1.3% | -70.7% | ||
| Q4 24 | 24.8% | 34.8% | ||
| Q3 24 | 27.6% | 28.0% | ||
| Q2 24 | 42.8% | 26.5% | ||
| Q1 24 | 26.9% | 14.7% |
| Q4 25 | 22.9% | -4.8% | ||
| Q3 25 | 29.2% | 32.8% | ||
| Q2 25 | 23.2% | 27.7% | ||
| Q1 25 | -0.6% | -90.9% | ||
| Q4 24 | 19.9% | 2.5% | ||
| Q3 24 | 21.1% | 4.0% | ||
| Q2 24 | 33.9% | -0.9% | ||
| Q1 24 | 21.4% | -5.6% |
| Q4 25 | $1.10 | $0.01 | ||
| Q3 25 | $1.42 | $0.23 | ||
| Q2 25 | $1.11 | $0.14 | ||
| Q1 25 | $-0.03 | $-0.23 | ||
| Q4 24 | $0.77 | $0.03 | ||
| Q3 24 | $0.84 | $0.02 | ||
| Q2 24 | $1.32 | $-0.01 | ||
| Q1 24 | $0.80 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $65.6M | $215.5M |
| Total DebtLower is stronger | $255.4M | — |
| Stockholders' EquityBook value | $420.0M | $-261.8M |
| Total Assets | $3.2B | $396.9M |
| Debt / EquityLower = less leverage | 0.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $65.6M | $215.5M | ||
| Q3 25 | $102.1M | $140.4M | ||
| Q2 25 | $103.1M | $92.9M | ||
| Q1 25 | $123.6M | $108.5M | ||
| Q4 24 | $47.3M | $88.6M | ||
| Q3 24 | $58.1M | $88.2M | ||
| Q2 24 | $86.3M | $105.5M | ||
| Q1 24 | $53.1M | $121.5M |
| Q4 25 | $255.4M | — | ||
| Q3 25 | $255.4M | $199.5M | ||
| Q2 25 | $255.4M | $199.3M | ||
| Q1 25 | $255.3M | $199.2M | ||
| Q4 24 | $255.3M | $199.0M | ||
| Q3 24 | $255.3M | $198.8M | ||
| Q2 24 | $255.3M | $198.6M | ||
| Q1 24 | $255.3M | $398.3M |
| Q4 25 | $420.0M | $-261.8M | ||
| Q3 25 | $408.6M | $-264.2M | ||
| Q2 25 | $395.2M | $-308.2M | ||
| Q1 25 | $386.9M | $-334.1M | ||
| Q4 24 | $303.3M | $-301.3M | ||
| Q3 24 | $306.8M | $-311.3M | ||
| Q2 24 | $289.3M | $-321.7M | ||
| Q1 24 | $279.9M | $-330.5M |
| Q4 25 | $3.2B | $396.9M | ||
| Q3 25 | $3.3B | $396.1M | ||
| Q2 25 | $3.3B | $342.9M | ||
| Q1 25 | $3.3B | $327.2M | ||
| Q4 24 | $2.4B | $350.9M | ||
| Q3 24 | $2.4B | $389.5M | ||
| Q2 24 | $2.5B | $395.6M | ||
| Q1 24 | $2.4B | $438.8M |
| Q4 25 | 0.61× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.84× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.91× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.6M | $74.6M |
| Free Cash FlowOCF − Capex | $52.6M | $74.6M |
| FCF MarginFCF / Revenue | 111.4% | 156.3% |
| Capex IntensityCapex / Revenue | 2.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | $92.2M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.6M | $74.6M | ||
| Q3 25 | $23.2M | $47.6M | ||
| Q2 25 | $17.8M | $-15.1M | ||
| Q1 25 | $-71.0K | $20.0M | ||
| Q4 24 | $39.8M | $15.2M | ||
| Q3 24 | $13.6M | $9.9M | ||
| Q2 24 | $9.7M | $33.5M | ||
| Q1 24 | $10.8M | $45.0M |
| Q4 25 | $52.6M | $74.6M | ||
| Q3 25 | $22.8M | $47.6M | ||
| Q2 25 | $17.6M | $-15.1M | ||
| Q1 25 | $-730.0K | $19.9M | ||
| Q4 24 | $38.8M | — | ||
| Q3 24 | $13.3M | $9.9M | ||
| Q2 24 | $9.4M | $33.4M | ||
| Q1 24 | $10.7M | $44.9M |
| Q4 25 | 111.4% | 156.3% | ||
| Q3 25 | 44.7% | 39.0% | ||
| Q2 25 | 35.0% | -17.7% | ||
| Q1 25 | -1.7% | 48.4% | ||
| Q4 24 | 117.0% | — | ||
| Q3 24 | 39.1% | 10.8% | ||
| Q2 24 | 28.3% | 35.4% | ||
| Q1 24 | 33.9% | 60.0% |
| Q4 25 | 2.3% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.4% | 0.0% | ||
| Q1 25 | 1.5% | 0.1% | ||
| Q4 24 | 2.9% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.9% | 0.1% | ||
| Q1 24 | 0.2% | 0.1% |
| Q4 25 | 4.96× | — | ||
| Q3 25 | 1.56× | 1.19× | ||
| Q2 25 | 1.52× | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.03× | 6.74× | ||
| Q3 24 | 1.88× | 2.71× | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
